104 related articles for article (PubMed ID: 38794935)
1. Tooth loss in breast cancer patients: A comparison between tamoxifen-treated and non-treated patients.
Julca-Baltazar JJ; Asmat-Abanto AS; Pantoja-Lázaro AR; Gorritti-Rubio AP; Minchón-Medina CA
Med Oral Patol Oral Cir Bucal; 2024 May; ():. PubMed ID: 38794935
[TBL] [Abstract][Full Text] [Related]
2. Association between tamoxifen and tooth loss in women with breast cancer.
de Araujo Sensever F; Jardim LC; Ferrazzo KL; Skupien JA; Antoniazzi RP
Support Care Cancer; 2022 Oct; 30(10):8193-8199. PubMed ID: 35796887
[TBL] [Abstract][Full Text] [Related]
3. [Trends in incidence and risk factors associated with the development of pancreatic cancer. Regional Institute of Neoplastic Diseases "Dr. Luis Pinillos Ganoza "- Iren North. 2008 - 2011].
Laban Villanueva CE; Díaz Plasencia JA; Yan Quiroz EF; Guevara Arrascue JL
Rev Gastroenterol Peru; 2012; 32(2):161-8. PubMed ID: 23023179
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
5. Real-world assessment of quality-of-life in patients with breast cancer treated with adjuvant endocrine therapy.
Akin Telli T; Ozturk MA; Alan O; Hasanov R; Kostek O; Arikan R; Basoglu T; Kaya S; Ercelep O; Akgul Babacan N; Dane F; Yumuk PF
Future Oncol; 2022 Jul; 18(22):2425-2439. PubMed ID: 35695547
[TBL] [Abstract][Full Text] [Related]
6. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.
Cuenca RE; Giachino J; Arredondo MA; Hempling R; Edge SB
Cancer; 1996 May; 77(10):2058-63. PubMed ID: 8640670
[TBL] [Abstract][Full Text] [Related]
7. SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment.
Abdel-Fatah TMA; Broom RJ; Lu J; Moseley PM; Huang B; Li L; Liu S; Chen L; Ma RZ; Cao W; Wang X; Li Y; Perry JK; Aleskandarany M; Nolan CC; Rakha EA; Lobie PE; Chan SYT; Ellis IO; Hwang LA; Lane DP; Green AR; Liu DX
Br J Cancer; 2019 Apr; 120(7):728-745. PubMed ID: 30816325
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
Lee M; Piao J; Jeon MJ
Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174
[TBL] [Abstract][Full Text] [Related]
9. Incidence of fractures in young women with breast cancer - a retrospective cohort study.
Stumpf U; Kostev K; Kyvernitakis J; Böcker W; Hadji P
J Bone Oncol; 2019 Oct; 18():100254. PubMed ID: 31440445
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04).
Takei H; Ohsumi S; Shimozuma K; Takehara M; Suemasu K; Ohashi Y; Hozumi Y
Breast Cancer Res Treat; 2012 May; 133(1):227-36. PubMed ID: 22234519
[TBL] [Abstract][Full Text] [Related]
11. Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial.
Leone JP; Cole BF; Regan MM; Thürlimann B; Coates AS; Rabaglio M; Giobbie-Hurder A; Gelber RD; Ejlertsen B; Harvey VJ; Neven P; Láng I; Bonnefoi H; Wardley A; Goldhirsch A; Di Leo A; Colleoni M; Vaz-Luis I; Lin NU
Cancer; 2021 Mar; 127(5):700-708. PubMed ID: 33290610
[TBL] [Abstract][Full Text] [Related]
12. Detection of a negative correlation between prescription of Chinese herbal products containing coumestrol, genistein or daidzein and risk of subsequent endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan between 1998 and 2008: A population-based study.
Hu YC; Wu CT; Lai JN; Tsai YT
J Ethnopharmacol; 2015 Jul; 169():356-62. PubMed ID: 25934515
[TBL] [Abstract][Full Text] [Related]
13. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
Goel S; Sharma R; Hamilton A; Beith J
Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD004562. PubMed ID: 19821328
[TBL] [Abstract][Full Text] [Related]
14. Influence of the anti-oestrogens tamoxifen and letrozole on thyroid function in women with early and advanced breast cancer: A systematic review.
Marina D; Rasmussen ÅK; Buch-Larsen K; Gillberg L; Andersson M; Schwarz P
Cancer Med; 2023 Jan; 12(2):967-982. PubMed ID: 35748065
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Patients at Increased Risk of Developing Type II Endometrial Cancer: Relative and Absolute Risk Estimation and Implications for Counseling.
Portela S; Cunningham A; Laios A; Hutson R; Theophilou G
Cureus; 2021 Jan; 13(1):e12981. PubMed ID: 33659121
[TBL] [Abstract][Full Text] [Related]
16. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
Bui KT; Willson ML; Goel S; Beith J; Goodwin A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
[TBL] [Abstract][Full Text] [Related]
17. Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.
Woodward WA; Barlow WE; Jagsi R; Buchholz TA; Shak S; Baehner F; Whelan TJ; Davidson NE; Ingle JN; King TA; Ravdin PM; Osborne CK; Tripathy D; Livingston RB; Gralow JR; Hortobagyi GN; Hayes DF; Albain KS
JAMA Oncol; 2020 Apr; 6(4):505-511. PubMed ID: 31917424
[TBL] [Abstract][Full Text] [Related]
18. Cell Division Cycle Associated 8 Is a Key Regulator of Tamoxifen Resistance in Breast Cancer.
Yu D; Shi L; Bu Y; Li W
J Breast Cancer; 2019 Jun; 22(2):237-247. PubMed ID: 31281726
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB
Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410
[TBL] [Abstract][Full Text] [Related]
20. Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols.
Balkenende EME; Dahhan T; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; Smeenk JMJ; Louwé LA; Cantineau AEP; de Bruin JP; Linn SC; van der Veen F; van Wely M; Goddijn M
Hum Reprod; 2022 Jul; 37(8):1786-1794. PubMed ID: 35776109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
